Chemomab Therapeutics (CMMB) Q2 2023 Earnings

Aug 14Confirmed
Aug 2022
Nov 2022
Q4 2022
Q2 2023
-0.72
-0.49
-0.26
-0.03

Details

Expected EPS
-0.03
Actual EPS
-0.72
Surprise EPS
-0.69
Surprise Percent
-2,300%

Description

⁨Chemomab Therapeutics⁩ (⁦CMMB⁩) has reported earnings of ⁦-0.72⁩ per share for ⁦Q2 2023⁩.

0 Comments

Share your thoughts